NCT02222974View on ClinicalTrials.gov

Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

August 31, 1999

Conditions
Healthy
Interventions
DRUG

BIIR 561 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY